AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 154 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $31,790,000 | +91.7% | 924,570 | +66.4% | 0.01% | +100.0% |
Q3 2014 | $16,585,000 | +59.3% | 555,610 | +7.1% | 0.01% | +50.0% |
Q2 2014 | $10,411,000 | -26.3% | 518,993 | -0.1% | 0.00% | -33.3% |
Q1 2014 | $14,127,000 | +14.4% | 519,768 | -12.7% | 0.01% | +20.0% |
Q4 2013 | $12,346,000 | -18.4% | 595,585 | -28.4% | 0.01% | -28.6% |
Q3 2013 | $15,136,000 | +29.8% | 831,690 | +18.6% | 0.01% | +16.7% |
Q2 2013 | $11,664,000 | – | 701,392 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |